Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TBC1D22A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PHYKPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ESRRA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM260 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSM11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POU2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAZ2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCOR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUFM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SF3A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALKBH3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DMRT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LDHD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP5D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on